TriStar Health Partners
VC Fund
Nashville, United States
TriStar Health Partners is an investment firm focused on pre-seed and seed stage healthcare innovation companies. It invests in life sciences, diagnostics, medical devices and technologies, IT, and healthcare companies. TriStar Health Partners was founded in 2009 and is based in Nashville, Tennessee.
- Total investments:
- 31
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries TriStar Health Partners invests in
Health CareSoftwareBiotechnologyMedicalInformation Technology
Stages TriStar Health Partners invests in
SeedFunding RoundSeries ASeries BSeries C
Countries TriStar Health Partners invests in
United States
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Brian Laden
|
|||
Christopher Rand
|
|||
Harry Jacobson
|
|||
|
Lisa McWilliams
|
|||
Investment Focus
Industry
- Health Care 12 (39%)
- Software 6 (19%)
- Biotechnology 6 (19%)
- Medical 4 (13%)
- Information Technology 4 (13%)
Stage
- Seed 6 (19%)
- Funding Round 6 (19%)
- Series A 4 (13%)
- Series B 3 (10%)
- Series C 2 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Brian Laden
Co-Founder and Partner
|
Co-Founder and Partner | Total investments: 0 | Find email | |
|
Christopher Rand
Partner & Co-Founder
|
Partner & Co-Founder | Total investments: 12 | Find email | |
|
Harry Jacobson
Partner
|
Partner | Total investments: 0 | Find email | |
|
Lisa McWilliams
Analyst
|
Analyst | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TVA Medical
|
TVA Medical, Inc. (TVA) is a medical device company developing innovative, minimally invasive therapies for treatment of End-Stage Renal Disease (ESRD). The company is funded by Santé Ventures. | Series C / Oct 06, 2015 | |
MedCenterDisplay
|
MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walksthrough the door.Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider. | $2.3M / Series B / Jul 09, 2015 | |
Nusirt
|
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents.NuSirts first product, NS-0100,uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies. | $6M / Series C / May 13, 2015 | |
Evermind
|
Evermind provides peace of mind to individuals living alone and the people who care about them.In the old days, people lived in supporting communities, surrounded by family and friends who could look out for them by simply observing signs of their daily activities. Clothing hanging on a line or smoke rising from a chimney signaled thatneighbors were safe and sound, without compromising their privacy. Evermind looks for modern-day signals of activity and well being by detecting when electrical appliances are switched on and off.With Evermind, daily rituals like making coffee in the morning or switching a bedside lamp off at night can serve as a simple check-in system, signaling that all is well without diminishing independence or requiring changes in routine. | $3.7M / Feb 19, 2015 | |
Advanced Catheter Therapies
|
Advanced Catheter Therapies, an early stage research and development medical device company, has a portfolio of innovative catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. ACT is developing a revolutionary device for restenosis (re-blockage of blood vessels) and as well as catheters forendovascular debulking (clearing of blocked blood vessels). | $3.4M / Series B / Aug 20, 2014 | |
|
MedCenterDisplay
|
MedCenterDisplay offers a multifunctional network that helps healthcare organizations connect with patients in a robust way. They focus on providing healthcare marketers with turn-key solutions backed by engaging, creative content. The company's digital signage systems allow healthcare organizations to reach each and every person who walksthrough the door.Developed and tested by physicians and medical staff, MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider. | $1.5M / Series B / Aug 18, 2014 | |
Molecular Sensing
|
Molecular Sensing, Inc. (MSI) is commercializing Back-Scattering Interferometry (BSI), the world’s first label-free, conformation-sensitive, free-solution assay technology for biophysical characterization of small molecule interactions with complex drug targets. This includes crude membrane protein preparations and other biochemically intractabletarget binding assays in native-like, free-solution environments — no tags or tethering | $2.7M / Series A / Jul 23, 2014 | |
InvisionHeart
|
InvisionHeart draws on the strengths of experienced leadership, robust software and hardware developers and a strong clinical advisory team.The technology was originally developed by a team of physicians and engineers at Vanderbilt University in response to real-world clinical problems.Along with their team of investors, they share a visionfor the improved care of heart patients wherever they live and work. | $1.9M / Series A / Jun 04, 2014 | |
Octovis, Inc.
|
Octovis expand the capabilities of nursing staff with live-streaming two-way video and real-time delivery of integrated medical device data, direct to a remote physician. Our Bluetooth enabled devices include a stethoscope, pulse oximeter, EKG, blood pressure cuff, otoscope, and a dermatoscope. These devices are connected to an Android tablet thatlive streams video between the nurse and remote physician (they connect via web browser); in addition to the data from the devices. The nurse can also don Vuzix smart glasses to transmit a live stream of video at their perspective, providing ‘eyes on site’. Organizations can use their own physicians, our partner PSO, or even a hybrid of both. We’ve built a robust platform between the nurse and physician, integrating into EHRs and providing intelligent dispatching algorithms to handle many concurrent encounters with a pool of available physicians. Our customers experience an increase in efficient, available, and effective care that helps them to drastically reduce hospital readmissions while providing more physician coverage than previously possible. | $30K / Seed / May 01, 2014 | |
Bjond
|
Bjond Inc. operates in the technology sector. The company was founded in 2012 and is based in Columbus, Ohio.Bjönd is automated workflow, real-time decision support and behavior change software that consumers and businesses use to change outcomes and lives in any industry . . . in any situation.Bjönd is designed to enable anyone - eventhose with little or no technical skills - to build interactive content and automated, expert workflows for any subject. | $3.3M / Series A / Apr 04, 2014 | |
| See all 31 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Software Investors
50,021 investors
Health Care Investors
43,014 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Medical Investors
18,848 investors
SaaS VC Funds
61,208 investors
Enterprise VC Funds
49,693 investors
FAQ
What does TriStar Health Partners invest in?
TriStar Health Partners invests primarily in Health Care, Software and Biotechnology startups, most often at Seed and Funding Round stage. Most of the 31 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact TriStar Health Partners?
Public channels for TriStar Health Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TriStar Health Partners?
The team at TriStar Health Partners includes Brian Laden (Co-Founder and Partner), Christopher Rand (Partner & Co-Founder) and Harry Jacobson (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
